Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
Main Author: | Herold Betsy C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-12-01
|
Series: | Retrovirology |
Similar Items
-
Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants
by: I. Rodríguez-Izquierdo, et al.
Published: (2022-03-01) -
Safety of G2-S16 Polyanionic Carbosilane Dendrimer as Possible HIV-1 Vaginal Microbicide
by: Alba Martin-Moreno, et al.
Published: (2022-02-01) -
Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems
by: Letícia Mesquita, et al.
Published: (2019-03-01) -
Safety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides <it>in vitro </it>testing algorithm
by: Jones Maureen, et al.
Published: (2010-07-01) -
G2-S16 dendrimer microbicide does not interfere with the vaginal immune system
by: Alba Martín-Moreno, et al.
Published: (2019-05-01)